← brief for 2026-10-31 · Slowing decline

Effectiveness of Erythropoiesis-Stimulating Agent Therapy with Oral and Intravenous Iron Supplementation in Achieving Hemoglobin Targets in Stage 5 Chronic Kidney Disease Patients

Article C Peer reviewed Observational

Key takeaways

This study looked at how to treat anemia in people with stage 5 kidney disease. It compared taking iron by mouth versus getting it through a vein. The study found that both methods can help raise blood counts. This is an observational study, so it shows a link, not proof of cause.

Who did this work

Restu Kristianto Noutema Zai (Universitas Sumatera Utara) · Yuandani Yuandani (Universitas Sumatera Utara) · Emil Salim (Universitas Sumatera Utara) · A G (Universitas Sumatera Utara)

Source

Article · OpenAlex, CKD works · 2026-10-30
https://doi.org/10.35451/jfm.v9i1.3691